Extended duration dual antiplatelet therapy evaluated

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Background

Treatment with aspirin and a P2Y12 inhibitor is commonly used in patients with cardiovascular disorders. The overall effect of such treatment on all-cause mortality is unknown. In the Dual Antiplatelet Therapy (DAPT) Study, continuation of dual antiplatelet therapy beyond 12 months af...